The Caring Ambassadors supports individuals in gaining control of their health care, regardless of the illness they face.

We provide information, tools, and resources to help those with any chronic health condition not only manage their health care after a diagnosis, but improve their quality of life and capacity for healing. As an advocacy organization, we both fight for patient rights and work to build a new generation of patient and health care champions. Our disease specific programs for Hepatitis C and Lung Cancer have been helping people obtain the support, assistance, and information they need for over 20 years.

To receive our weekly news updates in your inbox, CLICK HERE

Hepatitis C News
Week Ending August 19, 2019

Late Diagnosis of Hepatitis C Virus Infection, 2014-2016: Continuing Missed Intervention Opportunities
“Chronic hepatitis C virus (HCV) infection is typically asymptomatic until severe liver disease occurs and even then can remain undiagnosed for some time; thus, screening and treatment of asymptomatic persons are needed to prevent poor outcomes.”

CT Prisons May Spend $158M Treating Inmates for Hep C
“Facing a class action lawsuit, the Connecticut Department of Correction will begin testing and treating inmates for the hepatitis C virus, which can be spread by unprotected sex, intravenous drug use and tattooing, and thrives in a prison climate, the Hartford Courant reports.”

HCV-Specific T Cells Remain Functionally Impaired Despite HCV Clearance
“Hepatitis C virus (HCV)-specific T cells remain functionally impaired despite HCV clearance, which may explain why HCV cure does not lead to protective immunity and that reinfections can occur, according to study results published in the Journal of Hepatology.”

Status of, and Strategies for Improving, Adherence to HCC Screening and Surveillance
“Hepatocellular carcinoma (HCC) represents the second leading cause of cancer deaths worldwide and the main cause of death in patients with cirrhosis. Secondary prevention of HCC can be accomplished through the serial application of screening tests (ultrasound with or without alpha-fetoprotein) to detect the presence of subclinical lesions amenable to potentially curative treatment, such as surgery and ablation.”

Hepatitis C Drugs Reduce Liver-related Deaths by 46%
“A new study from the UT Southwestern Simmons Comprehensive Cancer Center demonstrates that antiviral drugs for hepatitis C reduce liver-related deaths by nearly 50% in patients with a history of liver cancer.”

Lung Cancer News
Week Ending August 19, 2019

Immunotherapies Show Promising Advancements in Small Cell Lung Cancer
“Although chemotherapy remains the standard treatment for small cell lung cancer (SCLC) in first- and second-line settings, notable progress in immunotherapies have recently taken place, begging the question of how these agents will be optimized in this tumor type.”

How Exercise ‘Prehab’ and Rehab Can Change the Game for Lung Cancer Patients
“Improving health and endurance before treatment, a process known as prehabbing, can help people with lung cancer do a lot better afterward.”

Treatment Success in Lung Cancer Is More Than Survival
“For patients with advanced lung cancer, successful treatment is defined not only as increasing survival but also maintaining quality of life and functionality in the process. “

The efficacy and safety of anlotinib treatment for advanced lung cancer
“Anlotinib is an oral novel multi-target tyrosine kinase inhibitor targeting vascular endothelial growth factor receptor, fibroblast growth factor receptor, platelet-derived growth factor receptor, and stem cell factor receptor (c-Kit).”

Olaparib Combo Shows Promise in Small Cell Lung Cancer
“Combining the PARP inhibitor olaparib (Lynparza) with temozolomide (Temodar) led to an overall response rate (ORR) of 41.7% in patients with relapsed small cell lung cancer (SCLC), according to findings from a phase I/II trial published in Cancer Discovery.”

Combinatorial therapy shows early promise in patients with relapsed small cell lung cancer
“The PARP inhibitor olaparib (Lynparza) in combination with the chemotherapeutic agent temozolomide (Temodar) showed clinical efficacy in patients with relapsed small cell lung cancer (SCLC), according to results from a phase I/II clinical trial published in Cancer Discovery, a journal of the American Association for Cancer Research.”

Scientists ‘get on the nerves’ of cancer cells
“Modulation of neuroreceptors can stop the growth of lung carcinoma (cancer) cells, according to a recent study conducted by a group of researchers from the Institute of Bioorganic Chemistry of the Russian Academy of Sciences (IBCh RAS) and the Moscow Institute of Physics and Technology (MIPT)”

The Desire for Life and Motherhood Despite Metastatic Lung Cancer
“Maria, a 30-year-old woman with a 3-month history of discomfort in her left hip, had a magnetic resonance imaging (MRI) scan that detected a 7-cm lesion in the left femur that was compatible with a tumor. Maria had already organized her wedding when she received the MRI results.”

New Quality Initiative for Patients With Advanced Lung Cancer Improves Care, Coordination
“Twenty to 30 years ago, delivering a diagnosis of lung cancer to a patient was a difficult conversation to have for many oncologists. But that has given way to greater optimism today, according to Mark A. Socinski, MD, executive medical director of AdventHealth Cancer Institute located in central Florida.”

The tumor suppressive roles of ARHGAP25 in lung cancer cells
“Several Rho GTPase-activating proteins (Rho GAPs) have been proved to serve as tumor suppressors in diverse human cancers. Among them, ARHGAP25 has also been found to be associated with hematopoietic cells and regulate phagocytosis. Little is known about the role of ARHGAP25 in lung cancer cells.”

VIDEO
ALK-Rearranged Lung Cancer

Integrative Health & Medicine News
Week Ending August 19, 2019

Why more depression treatments should include exercise
“After assessing numerous specialist studies, a new review concludes that exercise can help to both prevent depression and treat its symptoms.”

The Effects of Exercise on Your Appetite
“Are you hungry after you exercise? That might not be a problem if you’re at a healthy weight, but if you’re trying to shed extra pounds, the calories you take in could replace the ones you just worked so hard to burn off.”

3 Ways To Manage Hashimoto’s Naturally, According To An Integrative Doctor
“As an integrative physician, I’ve worked with thousands of patients over the past decade. One of the most common health issues I see is Hashimoto’s disease—an autoimmune disorder and the most common cause of hypothyroidism, or underactive thyroid.”

Acupuncture Is More Popular Than Ever—Here Are 4 Proven Benefits to Know About
“More people than ever swear by acupuncture for everything from alleviating chronic pain to tempering stress. Here’s what the pros have to say about this alternative remedy’s most common benefits.”

Food Into Medicine: How To Get It Done
“What you choose to eat every day comes with their own profound effects on the overall status of your health. Research shows that the dietary habits of an individual greatly influences the risk of diseases he may potentially suffer from.”

HERE’S HOW TO KNOW IF THAT SNACK YOU’RE EATING IS ACTUALLY A LEGIT MEAL
“In this age of I’m-too-busy-for-an-actual-meal, we have become a society of snackers. (Shout out to everyone literally eating a snack right now as you read this.) Walk into any drugstore and there’s at least half an aisle devoted to protein bars.”

Holistic Medicine: What to Know About This Trending Health Approach!
“Holistic” is one of those terms that bring forth positivity or skepticism. Yet, no matter what camp you fall into — holistic-gung-ho or skeptic — holistic practices and approaches to health have ventured out of the formerly segregated “spiritual realm” and are taking their rightful place in the medical world.”


Maryland University of Integrative Health Announces New Programs

“Maryland University of Integrative Health (MUIH) announced today that it has received approval from the Maryland Higher Education Commission to offer new and revised programs.”